Get my own profile
Public access
View all31 articles
3 articles
available
not available
Based on funding mandates
Co-authors
Ola EngkvistAstraZeneca R&D Gothenburg Orcid:0000-0003-4970-6461Verified email at astrazeneca.com
Lars CarlssonRTHS and CRML, University of LondonVerified email at rhul.ac.uk
Thierry KogejAssociate Principal Scientist, AstraZenecaVerified email at astrazeneca.com
Sorel MuresanR&D Manager HPC EMEA, Nouryon, Stenungsund SwedenVerified email at nouryon.com
Jiangming SunLund UniversityVerified email at med.lu.se
Yidong YangMolecular Oncology, BC Cancer Research CentreVerified email at bccrc.ca
Igor V. TetkoBIGCHEM GmbH & Helmholtz MunichVerified email at helmholtz-munich.de
Niklas BlombergDirector, ELIXIRVerified email at ebi.ac.uk
John G. Cumming, PhDExperienced medicinal chemist, AstraZeneca PharmaceuticalsVerified email at astrazeneca.com
Andrew M DavisAstraZeneca, Fisons, Astra, University of KentVerified email at astrazeneca.com
Markus FridenRIA iMed, AstraZenecaVerified email at astrazeneca.com
Antonio LlinàsRIA iMed AstraZenecaVerified email at astrazeneca.com
JG KennaPharmaceutical DirectorVerified email at safermedicines.org
Daniel WarnerSenior Credit Risk Analyst, Nimbla, London, UK.Verified email at nimbla.com
Antonsson MadeleineAstraZenecaVerified email at astrazeneca.com
Mats SvenssonVerified email at schrodinger.com